Garland J. Scott bought ELVN
February 12, 2026 · Form 4 insider transaction
Garland J. Scott bought 1,427 shares of Enliven Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,427
Price
$0.00
Total value
N/A
InsiderGarland J. Scott
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after1,427
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2026 annual meeting of the Issuer's stockholders or (ii) the date of the 2027 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.